These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 1913479)

  • 1. Hyperphosphatemia in multiple myeloma due to a phosphate-binding immunoglobulin.
    Mandry JM; Posner MR; Tucci JR; Eil C
    Cancer; 1991 Sep; 68(5):1092-4. PubMed ID: 1913479
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Spuriously high phosphate level which is promptly resolved after plasmapheresis in a patient with multiple myeloma.
    Kiki I; Gundogdu M; Kaya H
    Transfus Apher Sci; 2007 Oct; 37(2):157-9. PubMed ID: 18037346
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hyperphosphatemia in multiple myeloma.
    Oren S; Feldman A; Turkot S; Lugassy G
    Ann Hematol; 1994 Jul; 69(1):41-3. PubMed ID: 8061106
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Paraprotein interference with colorimetry of phosphate in serum of some patients with multiple myeloma.
    Sonnenblick M; Eylath U; Brisk R; Eldad C; Hershko C
    Clin Chem; 1986 Aug; 32(8):1537-9. PubMed ID: 3731447
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of methods to eliminate analytical interference in multiple myeloma patients with spurious hyperphosphatemia.
    Tian X; Zhao L; Ma J; Lu J; Zhu TY; Liu Y; Sun HX
    Lab Med; 2023 Nov; 54(6):598-602. PubMed ID: 36942666
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Spurious hyperphosphataemia caused by an IgA paraprotein: a topic revisited.
    Sinclair D; Smith H; Woodhead P
    Ann Clin Biochem; 2004 Mar; 41(Pt 2):119-24. PubMed ID: 15025801
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Spuriously elevated inorganic phosphate level in a multiple myeloma patient.
    Barutçuoglu B; Parildar Z; Mutaf I; Habif S; Bayindir O
    Clin Lab Haematol; 2003 Aug; 25(4):271-4. PubMed ID: 12890170
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Spurious hyperphosphatemia in multiple myeloma].
    Jarchovsky I; Beitner H; Plavnick L
    Harefuah; 1991 Dec; 121(12):515-6. PubMed ID: 1794758
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pseudohyperphosphataemia in multiple myeloma.
    Hawkins RC
    Ann Clin Biochem; 1991 May; 28 ( Pt 3)():226-8. PubMed ID: 1872566
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pseudohyperphosphatemia in a patient with multiple myeloma.
    Marcu CB; Hotchkiss M
    Conn Med; 2004 Feb; 68(2):71-2. PubMed ID: 15007869
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Phosphate disorders: hyperphosphatemia or pseudohyperphosphatemia?].
    Aeberhard N; Schild C; Rodondi N; Roten-Joss C; Tänzler K
    Praxis (Bern 1994); 2014 Oct; 103(20):1203-6. PubMed ID: 25270750
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Paraproteins: a regional South Australian experience.
    Roberts-Thomson PJ; Nikoloutsopoulos T; Smith AJ
    Asian Pac J Allergy Immunol; 2002 Sep; 20(3):187-95. PubMed ID: 12587843
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Spurious hypophosphatemia in a patient with multiple myeloma.
    Loghman-Adham M; Walton D; Iverius PH; Deiss A; Knight JA; Cheung AK
    Am J Kidney Dis; 1997 Oct; 30(4):571-5. PubMed ID: 9328375
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pseudohyperphosphataemia incidence in an automatic analyzer.
    Cohen AM; Magazanik A; van-der Lijn E; Shaked P; Levinsky H
    Eur J Clin Chem Clin Biochem; 1994 Jul; 32(7):559-61. PubMed ID: 7981338
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phosphate binding by a myeloma protein.
    Pettersson T; Hortling L; Teppo AM; Tötterman KJ; Fyhrquist F
    Acta Med Scand; 1987; 222(1):89-91. PubMed ID: 3115064
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pseudohyperphosphatemia and dysproteinemia.
    Busse JC; Gelbard MA; Byrnes JJ; Hellman R; Vaamonde CA
    Arch Intern Med; 1987 Nov; 147(11):2045-6. PubMed ID: 3675108
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypercalcaemia due to calcium binding by a polymeric IgA kappa-paraprotein.
    Pearce CJ; Hine TJ; Peek K
    Ann Clin Biochem; 1991 May; 28 ( Pt 3)():229-34. PubMed ID: 1872567
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Immunotyping Distribution of Serum Monoclonal Paraprotein and Environmental Impact on Multiple Myeloma (MM) and Monoclonal Gammopathy of Uncertain Significance (MGUS) in Taiwan: A Medical Center-Based Experience.
    Chang CC; Su MJ; Lee SJ; Tsai YH; Kuo LY; Lin IH; Huang HL; Yen TH; Chu FY
    Asian Pac J Cancer Prev; 2016; 17(1):395-9. PubMed ID: 26838245
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pseudohyperphosphataemia in patients with multiple myeloma.
    McClure D; Lai LC; Cornell C
    J Clin Pathol; 1992 Aug; 45(8):731-2. PubMed ID: 1401189
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.